# Response Pharmaceuticals jobs and careers

> 0 open roles at Response Pharmaceuticals as of October 23, 2026. Source: https://www.thejobsmap.com/company/response-pharmaceuticals

Response Pharmaceuticals is developing its lead asset, RDX-002, a first-in-class weight management and cardiometabolic health drug with confirmed efficacy and safety in >550 subjects. All programs are in Phase 2 clinical development. Our initial focus is on helping underserved patient populations taking antipsychotic medications for disabling mental illnesses to combat weight gain and metabolic dysregulation associated with these treatments. Antipsychotic-induced weight gain (AIWG) is a drug-induced epidemic within the already vulnerable population of patients with severe mental illness, and is contributing to a growing mortality gap between people with mental illness and the general population. Additionally, RDX-002 is being evaluated in other settings in which clinically significant weight gain and/or adverse metabolic changes are prevalent.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Founded | 2021 |
| Employees | 1 to 10 |
| Total funding | $11.9M |
| Industries | Biopharma, Biotechnology, Pharmaceutical |
| Website | https://responsepharmaceuticals.com |

## Common questions

### Is Response Pharmaceuticals hiring right now?

Response Pharmaceuticals has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on Response Pharmaceuticals's careers site.

### How do I apply for a job at Response Pharmaceuticals?

Pick a role on Response Pharmaceuticals's TheJobsMap page and select Apply. Every listing links to the original posting on Response Pharmaceuticals's own careers site, so you apply directly with the employer.